Intrexon (XON) Posts Q4 GAAP EPS of 19c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PTC
3. PCVX
4. META
5. AMD
6. SPY
7. RXO
8. USO
9. MSFT
10. GOOGL

Go back to Intrexon (XON) Posts Q4 GAAP EPS of 19c

Synthetic Biologics (SYN) SYN-005 Preclinical Results to Be Highlighted at ECCMID

March 2, 2015 8:41 AM EST

Synthetic Biologics, Inc. (NYSE: SYN) announced that preclinical results supporting the development of SYN-005 for the treatment of Pertussis will be highlighted at ECCMID 2015 (European Congress of Clinical Microbiology and Infectious Diseases), April 25-28, in Copenhagen, Denmark. Two posters will be presented under the Respiratory Infections category all four days at ECCMID on 50 ePoster stations, as follows:

Title: Antibody Cocktail Effectively Treats Pertussis in a Baboon Disease ModelAuthors: J. A. Maynard1, A. Nguyen1, E. Wagner1, J. Laber1, L. Goodfield2, W. Smallridge2, E. T.... More